MedTrace Logo

Evaluating an Internet-based Program for Anxious Adolescents

NCT02970734 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 563

Last updated 2019-05-02

No results posted yet for this study

Summary

Anxiety is a common mental health problem for Canadian adolescents. Anxiety that is diagnosed as a disorder and serious enough to require treatment affects up to 10% of all adolescents by the age of 16. The median age of onset is 11 years, making these disorders some of the earliest to develop. Anxiety disorders can have serious negative effects on a young person's personal relationships, school performance, and family life. These disorders may not be discovered by adolescents, parents and health care providers. Even if anxiety disorders are discovered, adolescents may not get the right therapy. Anxious adolescents can become sick if their anxiety is not treated properly. The investigators will carry out research to test Breathe, an Internet-based treatment for adolescents with anxiety problems. Adolescents can use this treatment from home via the computer. Breathe will include information materials and personalized homework assignments to help anxious adolescents learn ways to manage anxiety. More information can be found and www.TheBreatheStudy.com

Conditions

Interventions

BEHAVIORAL

Breathe

Six web-based cognitive behavioural therapy sessions. Telephone and email support are also provided during the program.

BEHAVIORAL

Resource Webpage

Static webpage listing anxiety resources.

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Amanda Newton · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2018-08-30
Completion
2018-11-22

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02970734 on ClinicalTrials.gov